P

Inventor

KLEYMANN GERALD

DE20 patents
⚠️ This page may combine multiple inventors who share the name “KLEYMANN GERALD”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INNOVATIVE MOLECULES GMBH

5 patents
US11278534B2Mar 22, 2022

Enantiomers of substituted thiazoles as antiviral compounds

INNOVATIVE MOLECULES GMBH6 citations84
US10590094B2Mar 17, 2020

Aminothiazole derivatives useful as antiviral agents

INNOVATIVE MOLECULES GMBH6 citations71
US12527778B2Jan 20, 2026

Enantiomers of a series of antiviral compounds

INNOVATIVE MOLECULES GMBH0 citations61
US12295945B2May 13, 2025

Enantiomers of substituted thiazoles as antiviral compounds

INNOVATIVE MOLECULES GMBH0 citations61
US12552756B2Feb 17, 2026

Deuterated aminothiazole compounds as antiviral compounds

INNOVATIVE MOLECULES GMBH0 citations50

JANSSEN PHARMACEUTICA NV

5 patents
US9850236B2Dec 26, 2017

Trifluoromethyl alcohols as modulators of RORγt

JANSSEN PHARMACEUTICA NV2 citations71
US10150762B2Dec 11, 2018

Trifluoromethyl alcohols as modulators of RORγt

JANSSEN PHARMACEUTICA NV0 citations52
US9861618B2Jan 9, 2018

Thiazoles as modulators of RORγt

JANSSEN PHARMACEUTICA NV0 citations52
US10080744B2Sep 25, 2018

Thiazoles as modulators of RORγt

JANSSEN PHARMACEUTICA NV0 citations51
US9845319B2Dec 19, 2017

Amide substituted thiazoles as modulators of RORyt

JANSSEN PHARMACEUTICA NV0 citations40

PHENEX PHARMACEUTICALS AG

3 patents
US9815851B2Nov 14, 2017

Pyrrolo carboxamides as modulators of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases

PHENEX PHARMACEUTICALS AG1 citations51
US9458104B2Oct 4, 2016

Carboxamide or sulfonamide substituted nitrogen-containing 5-membered heterocycles as modulators for the orphan nuclear receptor RORγ

PHENEX PHARMACEUTICALS AG2 citations51
US10301272B2May 28, 2019

Carboxamide or sulfonamide substituted thiazoles and related derivatives as modulators for the orphan nuclear receptor ROR[γ]

PHENEX PHARMACEUTICALS AG0 citations41

BAYER AG

2 patents
US7105553B2Sep 12, 2006

Thiazolyl amide derivatives

BAYER AG27 citations92
US6500817B1Dec 31, 2002

Thiazolyl urea derivatives and their utilization as antiviral agents

BAYER AG41 citations92

BAYER SCHERING PHARMA AG

1 patent
US7960387B2Jun 14, 2011

2-(3-phenyl-2-piperazinyl-3,4-dihydroquinazolin-4-yl)acetic acids as antiviral agents, especially against cytomegaloviruses

BAYER SCHERING PHARMA AG5 citations61

AICURIS GMBH & CO KG

1 patent
US7883713B2Feb 8, 2011

Topical application of thiazolyl amides

AICURIS GMBH & CO KG5 citations61

PHENEX DISCOVERY VERWALTUNGS GMBH

1 patent
US11078168B2Aug 3, 2021

Substituted N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase

PHENEX DISCOVERY VERWALTUNGS GMBH0 citations37

STEENECK CHRISTOPH

1 patent
US8946446B2Feb 3, 2015

Pyrrolo sulfonamide compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-γ (ROR-γ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune diseases

STEENECK CHRISTOPH0 citations37

KINZEL OLAF

1 patent
US8940722B2Jan 27, 2015

Compounds for modulation of orphan nuclear receptor RAR-related orphan receptor-gamma (RORγ, NR1F3) activity and for the treatment of chronic inflammatory and autoimmune disease

KINZEL OLAF0 citations36